ArticleJournal of Korean medical science2020
The Burden of Disease due to COVID-19 in Korea Using Disability-Adjusted Life Years.
Article in Journal of Korean medical science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 5 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
46 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- Integrated Clinical and Social Impacts of the COVID-19 Pandemic in Korea: A Combined Systematic and Narrative Review.Journal of Korean medical science · 2026Pooled it
- The burden of COVID-19 based on disability-adjusted life years: a systematic review of available evidence.Frontiers in public health · 2025Pooled it
- Disability-adjusted life years (DALYs) based COVID-19 health impact assessment: a systematic review.BMC public health · 2023Pooled it
- Systematic review of productivity loss among healthcare workers due to Covid-19.The International journal of health planning and management · 2022Pooled it
- Economic evaluation of programs against COVID-19: A systematic review.International journal of surgery (London, England) · 2021Pooled it
- Provincial Disparities in the COVID-19 Burden: Hospital Data Analysis from Iran.Medical journal of the Islamic Republic of Iran · 2026Article
- A state wise analysis of the socioeconomic and health impacts of the COVID-19 pandemic in India: lessons for future health system preparedness.Frontiers in public health · 2026Article
- Mapping the burden of COVID-19 infections and estimating the contribution of socioeconomic factors: a cross-sectional study.Archives of public health = Archives belges de sante publique · 2025Article
- Article
- COVID-19 burden in Iran: disability-adjusted life years analysis from hospital data, 2020-2021.Archives of public health = Archives belges de sante publique · 2024Article
- The mortality burden related to COVID-19 in 2020 and 2021 - years of life lost and excess mortality in 13 countries and sub-national regions in Southern and Eastern Europe, and Central Asia.Frontiers in public health · 2024Article
- Article
- Gender and age group-wise inequality in health burden and value of premature death from COVID-19 in India.Aging and health research · 2023Article
- Updating Korean Disability Weights for Causes of Disease: Adopting an Add-on Study Method.Journal of preventive medicine and public health = Yebang Uihakhoe chi · 2023Article
- Economic evaluation of strategies against coronavirus: a systematic review.Health economics review · 2023Review
- Years of life lost (YLL) associated with COVID-19 deaths in Khorasan-RAZAVI province, Iran.Journal of public health (Oxford, England) · 2023Article
- Burden of COVID-19 disease in Kurdistan province in west of Iran using disability-adjusted life years.Health science reports · 2023Article
- Cost-Benefit of Real-Time Multiplex PCR Testing of SARS-CoV-2 in German Hospitals.International journal of environmental research and public health · 2023Article
- Model-based estimation of burden of COVID-19 with disability-adjusted life years and value of statistical life in West Bengal, India.BMJ open · 2023Article
- Estimating the disability adjusted life years associated with COVID-19 in Iran for the first 2 years of the pandemic.Frontiers in public health · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe world is currently experiencing a pandemic of coronavirus disease 2019 (COVID-19). In Korea, as in other countries, the number of confirmed cases and deaths due to COVID-19 have been rising. This study aimed to calculate the burden of disease due to COVID-19 in Korea.
methodsWe used data on confirmed cases and deaths due to COVID-19 between January 20 and April 24, 2020 provided by the Korea Centers for Disease Control and Prevention, the local governments and the public media to determine disability-adjusted life years (DALYs) by sex and age. Morbidity was estimated directly among the confirmed, cured, and fatal cases. Disability weights were adopted from previous similar causes on the severity of COVID-19 for the years of life lived with disability (YLDs). The years of life lost (YLLs) were calculated using the standard life expectancy from the 2018 life tables for each sex and age.
resultsThe YLDs were higher in females (155.2) than in males (105.1), but the YLLs were higher in males (1,274.3) than in females (996.4). The total disease burden attributable to COVID-19 in Korea during the study period, was estimated to be 2,531.0 DALYs, and 4.930 DALYs per 100,000 population. The YLDs and the YLLs constituted 10.3% and 89.7% of the total DALYs, respectively. The DALYs per 100,000 population were highest in people aged ≥ 80 years, followed by those aged 70-79, 60-69, and 50-59 years, but the incidence was the highest in individuals aged 20-29 years.
conclusionThis study provided the estimates of DALYs due to COVID-19 in Korea. Most of the disease burden from COVID-19 was derived from YLL; this indicates that decision-makers should focus and make an effort on reducing fatality for preparing the second wave of COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.